1.87
+0.18(+10.65%)
Currency In USD
| Previous Close | 1.69 |
| Open | 1.76 |
| Day High | 1.88 |
| Day Low | 1.7 |
| 52-Week High | 1.88 |
| 52-Week Low | 0.91 |
| Volume | 902,885 |
| Average Volume | 162,251 |
| Market Cap | 110.79M |
| PE | -4.16 |
| EPS | -0.45 |
| Moving Average 50 Days | 1.33 |
| Moving Average 200 Days | 1.22 |
| Change | 0.18 |
If you invested $1000 in Vivani Medical, Inc. (VANI) 10 years ago, it would be worth $10.47 as of October 20, 2025 at a share price of $1.87. Whereas If you bought $1000 worth of Vivani Medical, Inc. (VANI) shares 5 years ago, it would be worth $716.56 as of October 20, 2025 at a share price of $1.87.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Vivani Medical Withdraws Record Date for Cortigent Neuromodulation Subsidiary Spin-Off
GlobeNewswire Inc.
Oct 03, 2025 12:30 PM GMT
The Company expects to reestablish and announce a new record date as soon as possibleALAMEDA, Calif., Oct. 03, 2025 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (NASDAQ: VANI) (“Vivani” or the “Company”), a clinical-stage biopharmaceutical company deve
Vivani Medical to Present at the Emerging Growth Conference on September 25, 2025
GlobeNewswire Inc.
Sep 24, 2025 1:15 PM GMT
ALAMEDA, Calif., Sept. 24, 2025 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (NASDAQ: VANI) (“Vivani” or the “Company”), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants, today announced that it will pres
Vivani Medical Announces Record Date for Spin-off of Cortigent Neuromodulation Subsidiary to Shareholders
GlobeNewswire Inc.
Sep 17, 2025 12:30 PM GMT
Cortigent is a leading developer of brain implant devices based on precision neurostimulation technology. It is the only company to have obtained FDA approval of a device providing artificial vision for the profoundly blind Cortigent’s new Orion® art